Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells

Cancer Letters

Volumn 179, Issue 2, 2002, Pages 151-156

  Sadava, David ^a,b   Phillips, Tiphanie ^a   Lin, Cindy ^a   Kane, Susan E ^b  

^a KECK GRADUATE INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Artemisinin; Drug resistance; Human lung cancer; Transferrin

Indexed keywords

ARTEMISIN; DEFEROXAMINE; DNA FRAGMENT; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; KINETICS; LUNG SMALL CELL CANCER; MALARIA; MULTIDRUG RESISTANCE; NICK END LABELING; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ARTEMISININS; CARCINOMA, SMALL CELL; CELL SURVIVAL; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; IN SITU NICK-END LABELING; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; RECEPTORS, TRANSFERRIN; SESQUITERPENES; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 0037188425     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00005-8     Document Type: Article

References (24)

1. Therapeutic advances in SCLC
2. Drug resistance in lung cancer
3. Resistance mechanisms in human lung cancer
4. Qinghaosu (artemisinin): An antimalarial drug from China
5. Artemisinin drugs in the treatment of malaria: From medicinal herb to registered medication
6. Current status of artemisinin and its derivatives as antimalarial drugs
7. Possible modes of action of artemisinin-type compounds
8. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study
9. Artemisinin drugs: Novel antimalarial agents
10. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells
11. Stability of artemisinin in aqueous environments: Impact on its cytotoxic action to Ehrlich ascites tumour cells
12. Stereochemistry-dependent cytotoxicity of some artemisinin derivatives
13. Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle
14. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat
15. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin
16. Transferrin receptors in human tissues: Their distribution and possible clinical relevance
17. Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug resistant KB cells
18. Transferrin and transferrin receptors in carcinoma of the breast
19. Transferrin receptors associate with drug resistance in cancer cells
20. Comparison of the kinetics of cycling of the transferrin receptor in the presence and absence of bound diferric transferrin
21. Characterization of an etoposide-resistant human small-cell lung cancer cell line
22. Markers for multi-drug resistance and its reversal in human small-cell lung cancer cells
23. Modulation of doxorubicin resistance in a doxorubicin-resistant human leukemia cell by an immunoliposome targeting transferrin receptor